RATING

RECOMMENDATION

Strong Buy

  • MEDI ASSIST HEALTHCARE SERVICES
  • ₹390.00

  • PLACE ORDER
  • ROFR Required
  • Available in Depository:

  • NSDL

  • CDSL

  • Available for Investment:

  • Primary

  • Secondary

RATING

RECOMMENDATION

Strong Buy

Business Type

Dominant Leader

RATING

RECOMMENDATION

Strong Buy

Business Type

Dominant Leader

MEDI ASSIST Profit and Loss

  • EBITDA

    The EBITDA of the company has witnessed a marginal growth of 5% in FY21 from FY20, which represents an aggregate increase of Rs. 4 Cr. The overall increase in the EBITDA is attributable to an increase in the revenue of the company

  • Total Revenue

    The total revenue of the company in FY21 has witnessed a steady growth of 5% from FY20. An increase in the revenue from operations is attributable to TPA fees, which had risen on account of the COVID-19 pandemic and an increase in health insurance premiums in India, which witnessed 13.3% growth in GDPI in FY21.

Financial Year

Total Revenue
COGS
Gross Profit
Raw Materials
Power & Fuel Cost
Employee Cost
Sales & Administrative Expenses
Operating & Other Expenses
EBITDA
Depreciation/ Amortization
PBIT
Interest & Income
Interest & Expense
Other Items
PBT
Taxes & Other Items
Net Income
Diluted EPS
Basic EPS
DPS
Payout Ratio
FY 2018

241.58

-

241.58

-

-

89.37

-

66.14

86.06

18.66

67.4

-

3.55

-

63.86

19.98

43.88

6.57

6.51

-

-

FY 2019

281.17

-

281.17

-

-

107.61

-

86.72

86.84

23.16

63.68

-

4.28

11.33

48.07

15.1

32.97

4.93

4.9

-

-

FY 2020

330.44

-

330.44

-

-

134.88

-

106.05

89.51

26.33

63.18

-

3.73

-

59.45

21.3

38.15

5.71

5.66

-

-

FY 2021

348.2

-

348.2

-

-

143.26

-

107.04

97.89

31.52

66.37

-

5.73

-

60.64

22.94

37.71

5.63

5.57

-

-

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ Cr

* denotes current year's data

  • MEDI ASSIST Annual Reports

2021

MEDI ASSIST - Annual Report - 2021

MEDI ASSIST - DRHP - 2021